Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis

Eur Psychiatry. 2024 Mar 15:1-26. doi: 10.1192/j.eurpsy.2024.25. Online ahead of print.NO ABSTRACTPMID:38487836 | DOI:10.1192/j.eurpsy.2024.25

Source: Journal of the Association of European Psychiatrists - March 15, 2024 Category: Psychiatry Authors: Shaoli Li Chenyue Xu Shaohua Hu Jianbo Lai Source Type: research